Bavarian Nordic A/S (BVNKF)
32.57
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Bavarian Nordic EPS Diluted (Quarterly) : 1.498 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.498 |
| March 31, 2026 | 0.0344 |
| December 31, 2025 | -0.5949 |
| September 30, 2025 | 2.186 |
| June 30, 2025 | 0.7074 |
| March 31, 2025 | 0.3965 |
| December 31, 2024 | 1.403 |
| September 30, 2024 | 0.1325 |
| June 30, 2024 | 0.4824 |
| March 31, 2024 | -0.2133 |
| December 31, 2023 | 1.694 |
| September 30, 2023 | -0.638 |
| June 30, 2023 | 1.009 |
| March 31, 2023 | 0.6967 |
| December 31, 2022 | 0.2908 |
| September 30, 2022 | 0.0232 |
| June 30, 2022 | -0.4822 |
| March 31, 2022 | -0.5827 |
| December 31, 2021 | -0.2405 |
| September 30, 2021 | -0.2018 |
| June 30, 2021 | -0.3817 |
| March 31, 2021 | -0.3563 |
| December 31, 2020 | -1.169 |
| September 30, 2020 | 0.0709 |
| June 30, 2020 | 0.2814 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.858 |
| December 31, 2019 | -0.1664 |
| September 30, 2019 | -0.3622 |
| June 30, 2019 | -0.3766 |
| March 31, 2019 | -0.3717 |
| December 31, 2018 | -0.3799 |
| September 30, 2018 | 0.1212 |
| June 30, 2018 | -0.43 |
| March 31, 2018 | -0.7442 |
| December 31, 2017 | -0.7133 |
| September 30, 2017 | 1.274 |
| June 30, 2017 | 0.1757 |
| March 31, 2017 | -0.0227 |
| December 31, 2016 | 0.3209 |
| September 30, 2016 | 0.3796 |
| June 30, 2016 | -0.1081 |
| March 31, 2016 | -0.5378 |
| December 31, 2015 | 0.0116 |
| September 30, 2015 | -0.2121 |
| June 30, 2015 | 0.258 |
| March 31, 2015 | 0.191 |
| December 31, 2014 | 0.4647 |
| September 30, 2014 | -0.0984 |
| June 30, 2014 | -0.3052 |
| March 31, 2014 | 0.0067 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Evaxion AS | -0.4464 |
| Genmab A/S | 0.4903 |
| Ascendis Pharma A/S | 3.522 |
| Zealand Pharma A/S | 8.610 |
| Agenus, Inc. | -0.0146 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 113.83M |
| Revenue (Quarterly) | 315.94M |
| Total Expenses (Quarterly) | 202.11M |
| Enterprise Value | 2.134B |
| Gross Profit Margin (Quarterly) | 60.45% |
| Profit Margin (Quarterly) | 36.03% |
| Earnings Yield | 9.59% |
| Operating Earnings Yield | 6.33% |
| Normalized Earnings Yield | 9.259 |